Category: AbbVie’s and Novartis AG

The Zacks Analyst Blog Highlights: Gilead Sciences, Kite Pharma, AbbVie’s and Novartis AG

  1. The Zacks Analyst Blog Highlights: Gilead Sciences, Kite Pharma, AbbVie’s and Novartis AG  Nasdaq
  2. Gilead-Kite: A New Transformative Deal For Biotech  Forbes
  3. Gilead Overpays; Next Takeout Targets  Barron’s
  4. Cool Your Hopes for a Post-Kite Cancer-Deal Boom  Bloomberg
  5. Full coverage

from Business – Google News http://www.nasdaq.com/article/the-zacks-analyst-blog-highlights-gilead-sciences-kite-pharma-abbvies-and-novartis-ag-cm839095

Advertisements